Research Reports News

The global vein illuminator market size is expected to reach USD 793.8 million by 2027, registering revenue based CAGR of 30.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing demand for easy visualization of inaccessible veins in neonates, elderly, dark skinned, and obese patients is expected to aid the market growth. Moreover, growing need for intravenous drugs for the treatment of various disorders is anticipated to further propel the product demand.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

As per the American Civil Liberties Union, 350,000 people in U.S. regularly use injectable drugs. The process requires proper knowledge regarding IV drugs in order to avoid infections that are caused due to injection drug use. Therefore, growing adoption of IV drugs for various purposes is expected to boost the adoption of vein illuminators for avoiding infections and enhancing proper treatment.

Growing demand for painless insertion in drawing blood or intravenous access is also expected to drive the market growth. These devices are mainly advantageous for the application in children and adults, as it reduces the risks of multiple needle pricks done to infants and old age patients. Illumination technology eases the job of clinicians by creating a road map of the main vein.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/vein-illuminator-market/request/rs1

Rising prevalence of chronic diseases worldwide is increasing the demand for diagnosis and treatment, which in turn is expected to drive the market growth. According to recent studies, it is estimated that around 500 million venipuncture procedures are performed every year. Usage of vein illuminator increases the success rate of venipuncture and hence enhances the diagnosis and treatment.

Vein Illuminator Market Report Highlights

• Infrared technology held the largest revenue share in 2020 and is expected to grow at the fastest rate during the forecast period mainly due to its ability to illuminate veins located deep inside the tissue for proper intravenous access and blood draw
• Transillumination technology is also expected to experience a significant growth during the forecast period because it uses LED lights, which enhances the structure of the vein
• The intravenous access segment held the largest revenue share in 2020 and is expected to register the fastest growth rate largely due to increasing usage of intravenous drugs for treatment of various chronic diseases
• The usage of vein illuminators is also increasing mainly because of growing demand for diagnosing chronic diseases and for avoiding the after effects or infections of multiple needle pricks
• The hospitals segment held the largest revenue share and is expected to experience the fastest growth rate during the forecast period increasing adoption in hospitals for streamlining the IV procedures with comfort
• North America dominated the vein illuminator market with the largest revenue share in 2020 owing to the presence of major market players and increasing product launches in the region
• Asia Pacific is expected to grow at the fastest growth rate during the forecast period mainly due to growing healthcare expenditure in the region and growing strategic alliances between the global players for distribution in the region

The global vein illuminator market size was valued at USD 94.3 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 30.6% from 2020 to 2027. It uses various technologies to accurately locate veins and projects its image on the skin. Usage of this device helps medical professionals minimize errors while finding puncture point.

These devices are highly portable and help reduce time and pain experienced during the puncture. Moreover, locating the veins of pediatric, geriatric, and obese patients is difficult, which could later lead to improper intravenous access of drugs. Adoption of vein illuminator is expected to show steep growth in small sized hospitals, emergency departments, and ambulatory care centers, thereby driving market growth.

End-use segments such as hospitals are widely adopting these illuminator devices to improve patient convenience. In June 2016, the Valley Hospital in Ridgewood invested in vein illuminators to ease the process of IV insertion and drawing of blood and also enhance the administration of IV medications.

As this devices is non-invasive, its approval rates in various countries are faster. In February 2018, AccuVein AV 400 was issued a medical device license for its usage in Canada. In addition, incorporation of various technologies in this device help in detailed imaging of the vein structure and enhance its usage in various applications such as blood draw, venipuncture, vascular procedures, cosmetic procedures, and other medical procedures.

Have a Query? Ask our experts:

https://www.grandviewresearch.com/inquiry/2976/ibb

Grand View Research has segmented the global vein illuminator market based on technology, application, end use:

Vein Illuminator Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)

• Transillumination
• Infrared
• Ultrasound

Vein Illuminator Application Outlook (Revenue, USD Million, 2016 - 2027)

• Intravenous Access
• Blood Draw
• Others

Vein Illuminator End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Blood Donation Camps
• Academic Institutions
• Others

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The U.S. healthcare staffing market size is expected to reach USD 26.7 billion by 2027, exhibiting a CAGR of around 5% over the forecast period, based on a new report by Grand View Research, Inc. Increasing geriatric population is leading to rising demand for healthcare services and shortage of nurses and other healthcare staff. The cost-effectivity of temporary staffing is likely to drive the market in the coming years.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

An increase in life expectancy has led to a rise in geriatric population. According to the National Institutes of Health, the number of people aged 65 years and above in U.S. is projected to nearly double from 48 million to 88 million by 2050. An aging population is expected to have a significant impact on healthcare delivery because they are highly susceptible to lifestyle diseases and chronic conditions.

According to the Bureau of Labor Statistics (BLS), around 526,800 nurses will retire over the next few years, creating a demand-supply gap. Also, according to the Association of American Medical Colleges, there will be a shortage of around 61000 to 94000 physicians by 2027. Shortage of physicians in the coming years is likely to drive the market in developed regions. In addition, increasing need for home healthcare workforce, such as nutritionists, dieticians, therapists, nurses, and home care aides, is also expected to aid the market growth.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/us-healthcare-staffing-market/request/rs1

Technology is currently one of the major drivers for increased healthcare employment. Advancements e have led to various innovations, such as medical informatics and telehealth, which have increased the need for skilled labor force to handle both technical and non-technical aspects of these devices. Hence, recruitment of new professionals along with training of existing ones has become essential.

Further key findings from the report suggest:

• The allied healthcare segment dominated the market in terms of revenue share in 2020. It includes medical technologists, physical therapists, respiratory therapists, occupational therapists, phlebotomists, and pharmacists
• The fastest growth is expected to be exhibited by the locum tenens segment owing to the cost-effectiveness of hiring temporary employees and an increase in the trend of physicians opting to work as locum tenens
• Some of the key players in the U.S. healthcare staffing market are AMN Healthcare; Envision Healthcare Corporation; Maxim Healthcare Services, Inc.; CHG Management, Inc.; inVentiv Health; Cross Country Healthcare, Inc.; TeamHealth; Almost Family; and Adecco Group
• Mergers, collaborations, and acquisitions are the key strategies undertaken by the players to improve their market position
• In November 2020, HNI Healthcare, Inc. acquired Martin Healthcare Group, a private company working across Florida and the Midwest, in order to expand its reach in the Midwest region of U.S.

The flexibility in work timings and attractive wages is expected to increase the number of individuals opting for allied healthcare as a career option. According to BLS, physician’s assistants, medical assistants, and pharmacy technicians are among the top 30 fastest-growing careers in U.S.

The U.S. healthcare staffing market size was valued at USD 17.0 billion in 2020 and is estimated to expand at a CAGR of around 5% over the forecast period. Some of the factors responsible for the market growth are increasing demand for temporary staffing for healthcare professionals due to rising geriatric population and lack of skilled nursing staff across the country.

An increase in life expectancy has led to a rise in geriatric population. According to the National Institutes of Health, the number of people aged 65 years and above in U.S. is projected to nearly double from 48 million to 88 million by 2050. An aging population is expected to have a significant impact on healthcare delivery because they are highly susceptible to lifestyle diseases and chronic conditions.

Have a Query? Ask our experts:

https://www.grandviewresearch.com/inquiry/6341/ibb

Grand View Research has segmented the U.S. healthcare staffing market based on service type:

U.S. Healthcare Staffing Service Type Outlook (Revenue, USD Million, 2016 - 2027)

• Travel Nurse Staffing
• Per Diem Nurse Staffing
• Locum Tenens Staffing
• Allied Healthcare Staffing

Based on service type, the U.S. healthcare staffing market has been segmented into per diem nurse, travel nurse, locum tenens, and allied healthcare. In 2020, travel nurses held majority of the market share in terms of revenue in 2020. On the other hand, the locum tenens segment is anticipated to grow at the fastest rate during the forecast period. The locum tenens segment had the highest penetration because hospitals and clinics prefer locum tenens in peak seasons, in the absence of permanent physicians as they are more cost-effective. Furthermore, physicians also prefer to work as locum tenens due to short-term assignments, to get varied clinical experience, flexible schedules, and travel opportunities.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global tissue sectioning market size is expected to reach USD 862.24 million by 2027, registering a CAGR of 6.56% during the forecast period, according to a new report published by Grand View Research, Inc. A rise in prevalence of cancer coupled with the awareness among physicians regarding the use of tissue diagnostic procedures for prognostication and diagnostics is expected to fuel the growth.

Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.

As per the NIH-National Cancer Institute, the number of new cancer cases is expected to rise to 23.6 million by 2030. Germany ranks in the top 5 countries that have super-aged societies. It is expected that one-third of the total population of Germany will be above 65 year of age by 2050. This increases the change of encountering cancer, liver and kidney disorders, autoimmune diseases, and infections.

As the analysis of tissue sections is helpful in the management and identification of clinical disorders, thus a rise in the geriatric population leads to a rise in demand for tissue sectioning equipment for effective and rapid tissue diagnostics. In addition, shifting focus of the researchers and pathologists toward exploring the cancer staging in rare types of cancer is anticipated to boost the market growth in the forthcoming years.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/tissue-sectioning-market/request/rs1

A rise in the number of histology laboratories globally is a key driving factor for the market. In addition, constant rise in the number of certified pathologists in Canada and other major countries is expected to support the projected growth of the market. These laboratories are adopting novel protocols that aid in troubleshooting the challenges associated with tissue processing.

Tissue Sectioning Market Report Highlights

• Instruments accounted for the largest market share in 2020 owing to the presence of a substantial commercially available product base, ongoing technological advancements, and lack of any external substitute for tissue sectioning equipment
• Rotary microtome is the most-commonly used microtomes in a histopathology lab, thereby leading to its prominent revenue share
• Automatic technology is expected to occupy substantial share of the technology segment in 2020 as these products enable cutting of thin tissue sectioning with a high precision consistently
• Automated devices also enhance productivity by enhancing the speed and efficiency of the process. These devices are user-friendly as they reduce the need for repetitive motion of the microtome
• Disease diagnosis dominated the applications segment in 2020 owing to a rise in adoption of histopathology techniques for the diagnosis of cancer and other disorders
• An accurate pathology analysis is crucial for the diagnosis and determination of a treatment plan for patients. This increases the utilization of microtomes and cryostats in histopathology laboratories for disease diagnosis
• Hospitals end-user segment is projected to continue holding the largest market share during the forecast period, as hospitals are the key facilities for the analysis of tissue specimen
• Presence of a large number of hospitals with in-house pathology laboratories for analysis of biopsy specimen is expected to boost the segment growth
• North America held the largest share of the tissue sectioning market in 2020. Asia Pacific, on the other hand, is expected to register the fastest CAGR in the forthcoming years
• Some key market players include Thermo Fisher Scientific, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, and Sakura Finetek Europe B.V.

The global tissue sectioning market size was worth USD 518.58 million in 2020 and is projected to register a CAGR of 6.56% over the forecast period. Rising prevalence of chronic diseases and cancers is one of the crucial factors driving demand for histopathology tests as a tissue pathology examination is of utmost importance for the diagnosis of a malignant tumor. Cancer is considered as one of the leading causes of death worldwide. Analysis of biopsy tissues enables pathologists to determine cancer type, stage, and the degree to which the disease has invaded healthy tissues. This has led to an increased adoption of histopathology and tissue sectioning and staining instruments, in turn propelling the market growth.

Growth of personalized therapeutics and diagnostics is expected to boost the market growth. Personalized medicine is becoming the hallmark of cancer treatment and with its application expanding to other fields. It is a constantly emerging approach toward customizing treatments based on the individual genetic buildup of patients. Rising adoption of personalized medicine has led to an increase in demand for the use of human tissue as the field relies on the use of human tissue for the development of innovative tests.

The rise in awareness programs undertaken by organizations, such as National Cervical Cancer Coalition, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the U.S. Preventive Services Task Force (USPSTF), for cancer screening, is a crucial factor driving the market growth. Efforts from major market players to undertake initiatives for creasing awareness about cervical and vaginal cancer screening is anticipated to bode well for the market growth.

Have a Query? Ask our experts:

https://www.grandviewresearch.com/inquiry/7110/ibb

For instance, the National Health Service (NHS) offers cervical screening programs for all women between 25 and 64 years of age in the U.K. Women aged between 25 years and 49 years are generally screened every three years, whereas women aged between 50 years to 64 years are screened every five years. The Norway government initiated the Norwegian Cervical Cancer Screening Programme (NCCSP) offers to screen women between 25 and 69 years, every three years.

Grand View Research has segmented the global tissue sectioning market report on the basis of product, technology, application, end-use:

Tissue Sectioning Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
  • Rotary Microtome
  • Sliding Microtome
  • Ultramicrotome
  • Cryostat
  • Others
• Accessories & Consumables
• Services

Tissue Sectioning Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Automatic
• Semiautomatic
• Manual

Tissue Sectioning Application Outlook (Revenue, USD Million, 2016 - 2027)

• Diagnosis
• Research

  The global tissue sectioning market size is expected to reach USD 862.24 million by 2027, registering a CAGR of 6.56% during the forecast period, according to a new report published by Grand View Research, Inc. A rise in prevalence of cancer coupled with the awareness among physicians regarding the use of tissue diagnostic procedures for prognostication and diagnostics is expected to fuel the growth.

  Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.

  As per the NIH-National Cancer Institute, the number of new cancer cases is expected to rise to 23.6 million by 2030. Germany ranks in the top 5 countries that have super-aged societies. It is expected that one-third of the total population of Germany will be above 65 year of age by 2050. This increases the change of encountering cancer, liver and kidney disorders, autoimmune diseases, and infections.

  As the analysis of tissue sections is helpful in the management and identification of clinical disorders, thus a rise in the geriatric population leads to a rise in demand for tissue sectioning equipment for effective and rapid tissue diagnostics. In addition, shifting focus of the researchers and pathologists toward exploring the cancer staging in rare types of cancer is anticipated to boost the market growth in the forthcoming years.

  To Request Sample Copy of this report, click the link:

  https://www.grandviewresearch.com/industry-analysis/tissue-sectioning-market/request/rs1

  A rise in the number of histology laboratories globally is a key driving factor for the market. In addition, constant rise in the number of certified pathologists in Canada and other major countries is expected to support the projected growth of the market. These laboratories are adopting novel protocols that aid in troubleshooting the challenges associated with tissue processing.

  Tissue Sectioning Market Report Highlights

  • Instruments accounted for the largest market share in 2020 owing to the presence of a substantial commercially available product base, ongoing technological advancements, and lack of any external substitute for tissue sectioning equipment
  • Rotary microtome is the most-commonly used microtomes in a histopathology lab, thereby leading to its prominent revenue share
  • Automatic technology is expected to occupy substantial share of the technology segment in 2020 as these products enable cutting of thin tissue sectioning with a high precision consistently
  • Automated devices also enhance productivity by enhancing the speed and efficiency of the process. These devices are user-friendly as they reduce the need for repetitive motion of the microtome
  • Disease diagnosis dominated the applications segment in 2020 owing to a rise in adoption of histopathology techniques for the diagnosis of cancer and other disorders
  • An accurate pathology analysis is crucial for the diagnosis and determination of a treatment plan for patients. This increases the utilization of microtomes and cryostats in histopathology laboratories for disease diagnosis
  • Hospitals end-user segment is projected to continue holding the largest market share during the forecast period, as hospitals are the key facilities for the analysis of tissue specimen
  • Presence of a large number of hospitals with in-house pathology laboratories for analysis of biopsy specimen is expected to boost the segment growth
  • North America held the largest share of the tissue sectioning market in 2020. Asia Pacific, on the other hand, is expected to register the fastest CAGR in the forthcoming years
  • Some key market players include Thermo Fisher Scientific, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, and Sakura Finetek Europe B.V.

  The global tissue sectioning market size was worth USD 518.58 million in 2020 and is projected to register a CAGR of 6.56% over the forecast period. Rising prevalence of chronic diseases and cancers is one of the crucial factors driving demand for histopathology tests as a tissue pathology examination is of utmost importance for the diagnosis of a malignant tumor. Cancer is considered as one of the leading causes of death worldwide. Analysis of biopsy tissues enables pathologists to determine cancer type, stage, and the degree to which the disease has invaded healthy tissues. This has led to an increased adoption of histopathology and tissue sectioning and staining instruments, in turn propelling the market growth.

  Growth of personalized therapeutics and diagnostics is expected to boost the market growth. Personalized medicine is becoming the hallmark of cancer treatment and with its application expanding to other fields. It is a constantly emerging approach toward customizing treatments based on the individual genetic buildup of patients. Rising adoption of personalized medicine has led to an increase in demand for the use of human tissue as the field relies on the use of human tissue for the development of innovative tests.

  The rise in awareness programs undertaken by organizations, such as National Cervical Cancer Coalition, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the U.S. Preventive Services Task Force (USPSTF), for cancer screening, is a crucial factor driving the market growth. Efforts from major market players to undertake initiatives for creasing awareness about cervical and vaginal cancer screening is anticipated to bode well for the market growth.

  Have a Query? Ask our experts:

  https://www.grandviewresearch.com/inquiry/7110/ibb

  For instance, the National Health Service (NHS) offers cervical screening programs for all women between 25 and 64 years of age in the U.K. Women aged between 25 years and 49 years are generally screened every three years, whereas women aged between 50 years to 64 years are screened every five years. The Norway government initiated the Norwegian Cervical Cancer Screening Programme (NCCSP) offers to screen women between 25 and 69 years, every three years.

  Grand View Research has segmented the global tissue sectioning market report on the basis of product, technology, application, end-use:

  Tissue Sectioning Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Instruments
    • Rotary Microtome
    • Sliding Microtome
    • Ultramicrotome
    • Cryostat
    • Others
  • Accessories & Consumables
  • Services

  Tissue Sectioning Technology Outlook (Revenue, USD Million, 2016 - 2027)

  • Automatic
  • Semiautomatic
  • Manual

  Tissue Sectioning Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Diagnosis
  • Research

  Tissue Sectioning End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Hospitals

    The global tissue sectioning market size is expected to reach USD 862.24 million by 2027, registering a CAGR of 6.56% during the forecast period, according to a new report published by Grand View Research, Inc. A rise in prevalence of cancer coupled with the awareness among physicians regarding the use of tissue diagnostic procedures for prognostication and diagnostics is expected to fuel the growth.

    Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.

    As per the NIH-National Cancer Institute, the number of new cancer cases is expected to rise to 23.6 million by 2030. Germany ranks in the top 5 countries that have super-aged societies. It is expected that one-third of the total population of Germany will be above 65 year of age by 2050. This increases the change of encountering cancer, liver and kidney disorders, autoimmune diseases, and infections.

    As the analysis of tissue sections is helpful in the management and identification of clinical disorders, thus a rise in the geriatric population leads to a rise in demand for tissue sectioning equipment for effective and rapid tissue diagnostics. In addition, shifting focus of the researchers and pathologists toward exploring the cancer staging in rare types of cancer is anticipated to boost the market growth in the forthcoming years.

    To Request Sample Copy of this report, click the link:

    https://www.grandviewresearch.com/industry-analysis/tissue-sectioning-market/request/rs1

    A rise in the number of histology laboratories globally is a key driving factor for the market. In addition, constant rise in the number of certified pathologists in Canada and other major countries is expected to support the projected growth of the market. These laboratories are adopting novel protocols that aid in troubleshooting the challenges associated with tissue processing.

    Tissue Sectioning Market Report Highlights

    • Instruments accounted for the largest market share in 2020 owing to the presence of a substantial commercially available product base, ongoing technological advancements, and lack of any external substitute for tissue sectioning equipment
    • Rotary microtome is the most-commonly used microtomes in a histopathology lab, thereby leading to its prominent revenue share
    • Automatic technology is expected to occupy substantial share of the technology segment in 2020 as these products enable cutting of thin tissue sectioning with a high precision consistently
    • Automated devices also enhance productivity by enhancing the speed and efficiency of the process. These devices are user-friendly as they reduce the need for repetitive motion of the microtome
    • Disease diagnosis dominated the applications segment in 2020 owing to a rise in adoption of histopathology techniques for the diagnosis of cancer and other disorders
    • An accurate pathology analysis is crucial for the diagnosis and determination of a treatment plan for patients. This increases the utilization of microtomes and cryostats in histopathology laboratories for disease diagnosis
    • Hospitals end-user segment is projected to continue holding the largest market share during the forecast period, as hospitals are the key facilities for the analysis of tissue specimen
    • Presence of a large number of hospitals with in-house pathology laboratories for analysis of biopsy specimen is expected to boost the segment growth
    • North America held the largest share of the tissue sectioning market in 2020. Asia Pacific, on the other hand, is expected to register the fastest CAGR in the forthcoming years
    • Some key market players include Thermo Fisher Scientific, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, and Sakura Finetek Europe B.V.

    The global tissue sectioning market size was worth USD 518.58 million in 2020 and is projected to register a CAGR of 6.56% over the forecast period. Rising prevalence of chronic diseases and cancers is one of the crucial factors driving demand for histopathology tests as a tissue pathology examination is of utmost importance for the diagnosis of a malignant tumor. Cancer is considered as one of the leading causes of death worldwide. Analysis of biopsy tissues enables pathologists to determine cancer type, stage, and the degree to which the disease has invaded healthy tissues. This has led to an increased adoption of histopathology and tissue sectioning and staining instruments, in turn propelling the market growth.

    Growth of personalized therapeutics and diagnostics is expected to boost the market growth. Personalized medicine is becoming the hallmark of cancer treatment and with its application expanding to other fields. It is a constantly emerging approach toward customizing treatments based on the individual genetic buildup of patients. Rising adoption of personalized medicine has led to an increase in demand for the use of human tissue as the field relies on the use of human tissue for the development of innovative tests.

    The rise in awareness programs undertaken by organizations, such as National Cervical Cancer Coalition, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the U.S. Preventive Services Task Force (USPSTF), for cancer screening, is a crucial factor driving the market growth. Efforts from major market players to undertake initiatives for creasing awareness about cervical and vaginal cancer screening is anticipated to bode well for the market growth.

    Have a Query? Ask our experts:

    https://www.grandviewresearch.com/inquiry/7110/ibb

    For instance, the National Health Service (NHS) offers cervical screening programs for all women between 25 and 64 years of age in the U.K. Women aged between 25 years and 49 years are generally screened every three years, whereas women aged between 50 years to 64 years are screened every five years. The Norway government initiated the Norwegian Cervical Cancer Screening Programme (NCCSP) offers to screen women between 25 and 69 years, every three years.

    Grand View Research has segmented the global tissue sectioning market report on the basis of product, technology, application, end-use:

    Tissue Sectioning Product Outlook (Revenue, USD Million, 2016 - 2027)

    • Instruments
      • Rotary Microtome
      • Sliding Microtome
      • Ultramicrotome
      • Cryostat
      • Others
    • Accessories & Consumables
    • Services

    Tissue Sectioning Technology Outlook (Revenue, USD Million, 2016 - 2027)

    • Automatic
    • Semiautomatic
    • Manual

    Tissue Sectioning Application Outlook (Revenue, USD Million, 2016 - 2027)

    • Diagnosis
    • Research

    Tissue Sectioning End-use Outlook (Revenue, USD Million, 2016 - 2027)

    • Hospitals
    • Clinics
    • Diagnostic Laboratories
    • Research Centers

    About Grand View Research

    Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

     

  • Clinics
  • Diagnostic Laboratories
  • Research Centers

  About Grand View Research

  Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

   

Tissue Sectioning End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Clinics
• Diagnostic Laboratories
• Research Centers

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global healthcare staffing market size is likely to reach USD 48.6 billion by 2027 at a CAGR of 5.4% over the forecast period, based on a new report by Grand View Research, Inc. The rising demand for temporary nursing staff especially due to growing geriatric population is boosting the scope for these services across the world.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

In 2010, the Association of American Medical Colleges estimated that U.S. might face a shortfall of 150,000 doctors during the next 10-15 years. In August 2019, the National Association of Locum Tenens Organizations (NALTO) stated that 90% of the U.S. healthcare facilities use locum tenens providers and over 50,000 physicians work on locum tenens projects every year. The increasing number of physicians choosing to work as locum tenens is expected to propel the market growth over the forecast period.

Furthermore, the hospitals are forced to reduce the staff and implement policies for ensuring the availability of nurses upon an increase in the workload, in response to the pressure of costs. Due to high penetration of the market, there is the availability of healthcare staff during emergencies, thereby driving the market growth.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/healthcare-staffing-market/request/rs1

Healthcare Staffing Market Report Highlights

• By service, the market has been segmented into travel nurse, per diem nurse, locum tenens, and allied healthcare, out of which, the travel nurse segment dominated the market in terms of revenue share in 2019
• Locum tenens are anticipated to witness a significant growth rate over the forecast period owing to rising number of physicians opting to work as locum tenens and due to the cost-effectiveness to the providers
• North America held a majority of the market share in 2019 due to shortage of skilled professionals in the region, local presence of several market players, and overall growth in geriatric population
• Asia Pacific is expected to register the highest growth rate over the forecast period due to increasing awareness regarding contract staffing, promising economic outlook, and increasing investments by various market players
• Some of the key players operating in the healthcare staffing market are AMN Healthcare; Envision Healthcare Corporation; Maxim Healthcare Services, Inc.; CHG Management, Inc.; inVentiv Health; Cross Country Healthcare, Inc.; TeamHealth; Adecco Group; and Almost Family.

The global healthcare staffing market size was valued at USD 31.8 billion in 2019 and is expected to register a CAGR of 5.4% over the forecast period. A significant rise in geriatric population has been one of the major contributing to market growth over the past few years. Increasing awareness regarding the benefits of temporary staffing, job related perks, and availability of opportunities across the country are some of the factors contributing to the market growth.

For the last few years, the healthcare industry is facing a shortage of skilled medical practitioners globally. For instance, according to the World Health Organization (WHO), in 2013, there was a shortfall of 7.2 million healthcare workers across the globe and the number is projected to reach 12.9 million by 2035.

According to the U.S. Bureau of Labor Statistics, the average annual income for nurses was around USD 75,000 in 2018. Moreover, increasing shortage of healthcare professionals is expected to increase the salaries of nurses, in-turn attracting more individuals to opt for a career in the field of healthcare staffing. The increased flow of healthcare professionals will help in enduring the problem of staff shortage.

Have a Query? Ask our experts:

https://www.grandviewresearch.com/inquiry/4856/ibb

Grand View Research has segmented the global healthcare staffing market based on service type:

Healthcare Staffing Service Type Outlook (Revenue, USD Million, 2016 - 2027)

• Travel Nurse Staffing
• Per Diem Nurse Staffing
• Locum Tenens Staffing
• Allied Healthcare Staffing

Clinical experience at different locations, short-term assignments, travel opportunities, and flexible schedules are attracting travel nurses and locum tenens, further boosting the market growth. A survey published by Avant Healthcare Professionals stated that around 50% of hospitals in U.S. reported job openings for temporary nurses and over 60% of the hospitals were expecting retirements of nurses in 2019. Also, the trend of appointing travel nurses saw an increase of 7% in 2019. These factors are anticipated to significantly boost the demand for healthcare staffing in U.S.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ageing and wrinkling of the skin - two words that have scared the living daylights out of men and women, old and young alike. And then enters the knight in shining armor (or bottle), that is hyaluronic acid….

The North America OTC hyaluronic acid market size was valued at USD 26.14 billion in 2015 and is projected to grow at a CAGR of 5.9% during the forecast period. The OTC hyaluronic acid market in North America is majorly driven by factors such as the presence of a large population aged between 25 and 55 years in the U.S. and the growing consciousness amongst this age group regarding skin care procedures.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

Hyaluronic acid, also known as hyaluronan, is an anionic, non-sulfated glycosaminoglycan and is a gooey, clear substance which is produced naturally by the human body. It is mostly found in the skin, eyes and connective tissues, and its main objective is to keep human tissues moist and well lubricated. It is distributed throughout epithelial, connective and neural tissues. Majority of the consumers use it as a supplement, but it can also be used in topical serums, injections and eye drops. Additionally, it helps in maintaining normal joint cushioning, and all these factors help the product in exhibiting its properties in varied fields such as ophthalmology, dermatology, rheumatology, orthopedic surgery, otolaryngology, plastic surgery, drug delivery, and wound healing.

HA, when applied topically, helps to hydrate the skin and then functions as a humectant to maintain this hydration. A single gram of HA can hold up to 6 liters of water, which is A LOT! With regards to the skin, HA holds so many advantages that you need not download any application to beautify your pictures on your smartphone! It offers a super-soft, plump and cushioned feel to the skin, and works wonders for those with an ageing skin. The best thing is, it can work on ANY type of skin, and as it also has antioxidant properties, it shields the skin against pollution and other uncontrollable elements. However, there are two sides of a coin, and there may be cases of reddening and irritation of the skin, if the hyaluronic acid routine is overdone.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/north-america-otc-hyaluronic-acid-ha-market/request/rs1

With Regards To The North American Market…

North America holds a prominent share in the global market for hyaluronic acid, both in terms of availability of the product as well as innovations carried out by major companies. The younger demographic has shifted their mentality towards procuring locally sourced, sustainable and organic solutions, as compared to following the major brands.

According to Nielsen, the total sales value of OTC drugs in the United States was USD 35,231 million as of 2018. Additionally, according to Statista, the OTC pharmaceuticals segment in Canada amounts to USD 2,697 million in 2020. The regional population comprises of the growing aging population and the shrinking household population. Many factors are playing a role in solidifying the North America OTC Hyaluronic Acid market for the product, with some of them being:

• Customers are becoming more brand conscious about cosmetic products. Thus, brands are diversifying their product portfolio to target new customer groups by shifting their focus from the younger generation to the middle-aged population.
• The growing elderly population serves as an important driver for this market. The ever-rising demand for organic and natural products coupled with the development of anti-aging products addressing a variety of cosmetic concerns, including skin wrinkling, skin type- & skin tone type-related issues, dark circles, and hyperpigmentation, is anticipated to support market growth in the future.
• The growing usage of hyaluronic acid in anti-aging or anti-wrinkle creams and the rapidly growing anti-aging market are some of the key factors indicating the increasing demand for the product in the dermatology market.
• The increasing prevalence of arthritis and joint-related problems amongst the geriatric population has resulted in an upsurge in the demand for joint supplements, thus creating more opportunities for HA in the major regional economies such as U.S. and Canada.
• Additionally, the presence of a considerably large target population is further accounting for the high market share for hyaluronic acid across this region.

According to various reports, the Hispanic population is more progressive and have high demand for specialty products. In addition, this population comprises impulsive buyers who are inclined toward sophisticated cosmetic products in the high price range. Hispanic population in the United States reached almost 60 million in 2018, and has seen a continued climb, while the Southern U.S. states have seen fastest climb in the population at 33%, when compared to 2008 data. The presence of almost 45% of the white Hispanic population in the U.S. is expected to affect the market to a great extent. However, the non-Hispanic population that accounted for almost 41% of the population birth in 2014 is the highest spender in the cosmetic industry and is expected to drive the market in the forecast period.

Have a Query? Ask Our Experts:

https://www.grandviewresearch.com/inquiry/4273/ibb

Innovation And Developments Ruling The Market

Some of the major competitors that have been involved in this exciting and innovative space include Shiseido Co., Ltd.; Lindberg Nutrition & GeniusCentral Systems; Nature’s Way Products, LLC; NOW Foods; NeoCell Corporation; Source Naturals, Inc.; Doctors Best; derma e; and Earth Science Naturals. Besides, research institutions are also digging deep to search for avenues that can be explored by using this product. Recent events and developments in the industry include:

• Study results published in Arthritis Research & Therapyhave shown that filler injections of hyaluronic acid and platelet-rich plasma can vastly improve the quality of life in scleroderma patients. The study came out in December 2019.
• Biomedical engineers at Rutgershave successfully developed a "bio-ink" for 3D printed materials, making use of modified versions of polyethylene glycol and hyaluronic acid, which would serve as a scaffold for the purpose of growing tissues. This study was published in the Biointerphases journal.
• The Revitalift Filler Serum by L'Oréal Paris, which is hugely popular in the U.S. has been made available in the United Kingdom. The product contains 1.5% HA, which is more than the standard product concentration. Reportedly, 1 unit is sold in the U.S. every minute.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global structural heart devices market size is expected to reach USD 9.1 billion by 2025, based on a new report by Grand View Research, Inc. The market is expected to witness an exponential growth over the next 8 years due to the rapid increase in cardiovascular conditions and increasing power of healthcare expenditure.

It’s a well-known fact that heart defects have gripped a large proportion of the world population, as the harms of following unhealthy lifestyle habits have started to take a toll on people’s health. With surgeries related to structural heart diseases on the rise, structural heart devices have proved mightily helpful in medical scenarios.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

Some Quick Facts….

• Nearly 5 million Americanscurrently are suffering from congestive heart failure. Approximately 550,000 new cases of CHF are discovered in the S. each year.
• A report by the American Heart Associationstated that 1 out of 3 Americans in 2016 succumbed to cardiovascular diseases, of which CHD and heart failure were responsible for more than half of those deaths.
• Nearly one out of 100 births(i.e., 40000 births) in the United States every year is affected with CHD, with one-fourth of these babies suffering from critical CHD.
• Diseases of the heart have been the major cause of deaths not only in the US, but also worldwide, with WHO stating them as the leading global cause of death. The total number of people who succumbed to CVDs stood at 17.9 million in 2016 globally

All these figures are indeed a cause of concern for us common citizens. A good proportion of the global population is focused on following a healthy lifestyle. However, still more are stuck on an unhealthy one, which act as an open invitation to such diseases. Most structural heart conditions are congenital, but they may also be acquired later in life.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/structural-heart-devices-market/request/rs1

Structural Heart Devices Have Opened New Avenues In Treatment

Till some time back, the way of treatment for such conditions was an open heart surgery. However, catheterization has since surpassed it. The presence of the structural heart devices market has provided surgeons the advantage of performing minimally invasive procedures. Transcatheter procedures are preferred over open-heart surgeries due to advantages such as lesser recovery time and procedural risk. It also avoids cardiopulmonary bypass, which reduces risk, thereby giving enhanced patient care. Operator expertise adds to the improved results of these procedures as compared to open-heart procedures. Also, patients incur less expenses owing to the shorter stay in the hospital.

Positive clinical evidence of structural heart devices are resulting in their increased use in the treatment of CHD. Similarly, other data supporting the results such as the STS National Database and American Heart Association Abstracts also encourage surgeons to conduct these procedures. Guidelines by the American College of Cardiology, American Stroke Association, and American Heart Association also standardize the procedures, thereby reducing the intraoperative risks and improve the outcomes of the surgeries.

Types Of Structural Heart Devices

Structural heart devices are classified into four types - surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR), mitral repair, and left atrial appendage closure (LAAC).

• Surgical aortic valve replacement (SAVR)- It is a type of open heart surgery that is performed in order to replace a diseased aortic valve. Typically, the process is more invasive than TAVI and need the patient to be placed on a heart and lung machine, under general anesthesia.
• Transcatheter aortic valve replacement (TAVR)- This is a minimally invasive procedure for replacing a narrowed aortic valve that does not open properly (aortic valve stenosis). TAVR is also known as transcatheter aortic valve implantation (TAVI). It can be performed on patients at intermediate or high risk of complications from SAVR, as well as certain people who cannot undergo open heart surgery.
• Mitral repair- Also known as annuloplasty. It is a procedure for tightening or reinforcing the annulus around a heart valve. The procedure can be performed during open-heart surgery as well as minimally-invasive heart surgery.
• Left atrial appendage closure(LAAC) - A procedure that closes the opening of the left atrial appendage. This is recommended in cases of atrial fibrillation, wherein the blood cannot be effectively squeezed out from the left atrium, leading to its collection in the left atrial appendage, increasing chances of a stroke.

Shining A Light On The Structural Heart Device Market Scenario

Aging population is driving the overall healthcare segment across the globe. Moreover, increasing focus on the quality of life of this group is further boosting the health care space, which extends to the structural heart devices industry. Cardiac disorders are highly common and people are aware of the consequences and readily seeking treatments for the same. These defects may be present at birth or may occur late in life due to wear & tear of the tissues. This adds to the already existing lifestyle diseases related to heart and results in occurrence of stroke. Thus, operations to reduce the risk of stroke are gaining roots in the market, which is expected to drive the structural heart devices market.

Browse Press Release of this report:

https://www.grandviewresearch.com/press-release/global-structural-heart-devices-market

Asia Pacific is expected to be the most lucrative region for the industry. This can be attributed to the rapidly increasing geriatric population, presence of a large patient base, growing awareness & increased healthcare expenditure, and efforts of industry players to enter the market by introducing new products. North America held the largest share in the structural heart devices market in 2016, while it is expected to maintain its dominance over the coming years, with a strong preference for minimally invasive procedures factoring in its growth in the region. 

Competitors Stepping Up Their Game

Several regional and international players are operating in the structural heart devices market. Some of the key players are Biomerics, Boston Scientific Corporation, Medtronic, CardioKinetix, Edwards Lifesciences Corporation, Abbott Laboratories, LivaNova PLC, Comed BV, JenaValve Technology, Inc., and ST. JUDE MEDICAL. Key developments that the structural heart devices industry has seen in the past year include:

• In December 2019, Biomericsand ATL Technology dissolved their joint venture Biomerics ATL LLC, with the former purchasing ATL Technology’s interests in the JV. The business unit will be renamed as Biomerics CRI. The Biomerics ATL JV began with the asset acquisition of CRI Medical, and its facilities in Indiana and Costa Rica in 2018.
• In August 2019, the US FDAapproved Medtronic’s Evolut™ Transcatheter Aortic Valve Replacement (TAVR) system for patients with symptomatic severe native aortic stenosis, who are at a low risk of surgical mortality. The approval comes on the back of a multi-center Evolut Low Risk Trial that monitored and evaluated 3 valve generations in more than 1400 patients.
• In March 2019, Boston Scientificreceived the CE Mark for its next-generation WATCHMAN FLX™ Left Atrial Appendage Closure Device, paving way for a limited market release in Europe. The device is intended to reduce stroke risk in people with non-valvular AF.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global pacemaker market size is expected to reach USD 10.3 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 7.2% CAGR during the forecast period. Heightening prevalence of cardiac conditions, coupled with rising availability of medical coverage, is a key driving factor governing the growth of the pacemaker market globally. In addition, technological enhancements in these devices are supporting market expansion.

Life is the not only a most important thing, but also

To save and prolong this precious thing, man has gone over to achieve several feats with the help of science and technology, and has developed healthcare and life saving technology to such a level, that astonishes us to the core.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

When we talk about heart pacemaker, we talk about the same level of developed healthcare technology, which is proving out to be a lifesaver in literal meaning. Pacemaker or ‘Artificial Cardiac Pacemaker’ was developed Wilson Greatbatch in 1958, along with the pacemakers batteries. And since it has been developed, it has helped multiple people prolong their lives. As of 2016, 1.14 million pacemakers are in use globally; and the numbers are going to rise to 1.43 million units by the year 2023. Therefore, the Global Pacemaker Market is certainly receiving great demand, which is expected to reach USD 10.3 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 7.2% CAGR.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/pacemaker-market/request/rs1

Brief on Cardiac Pacemaker

Cardiac pacemaker is one of the cardiovascular medical devices, which controls the functioning of the heart using electrical impulses that artificially contract the heart muscles. A block in the heart’s electrical conduction system may result in failure of the natural pacemaker in the heart. It generates electrical impulses delivered by electrodes to cause the heart muscle chambers (the upper, or atria and/or the lower, or ventricles) to contract and therefore pump blood; by doing so this device replaces and/or regulates the function of the electrical conduction system of the heart.

Types

These artificial pacemakers are of two types, external and implantable. External pacemakers are used in case of emergencies with continuous monitoring in intensive care units at hospitals. External pacemakers also include wearable pacemakers, but due to portability and performance issues, these devices are rarely used. The benefit of the internal pacemakers over the external ones makes them the comfortable choice for the patient and can be aptly understood by the pie-chart below.

Implantable pacemakers are of the three types, single chamber, dual chamber, and biventricular, and are inserted through a simple surgery, using general anesthesia. In single chamber pacemakers, a single lead is implanted into one of the heart chambers, the atrium or the ventricle; while in dual chamber pacemakers, two leads are placed in the ventricle and the atrium. Dual chamber pacemaker functioning closely resembles that of the natural pacemaker present in the human body.

The biventricular pacemaker also known as Cardiac Resynchronization Therapy (CRT) is used in patients with a lack of synchronization between the contractions of the left and right ventricles, a condition known as ventricular dysynchrony. These devices consist of a couple of leads, one stimulates the septum and the other stimulates the epicardial wall of the left ventricle.

Have A Query? Ask Our Expert:

https://www.grandviewresearch.com/inquiry/675/ibb

Pacemaker: Market Snapshot

The key drivers impacting the growth of the pacemaker market include:

• Increasing incidence of Cardiovascular Diseases (CVDs)
• Technological advancement in pacemakers
• Availability of reimbursement for pacemaker implantation procedures

Above factors push the demands in the market and boost the competition, which leads to greater technological advancements along with research and development in the sector. New product development, geographical expansion, collaboration, mergers and acquisitions, and pricing strategies are key undertakings of players in this space. For Instance, in July 2016, St. Jude Medical received U.S. FDA approval for SyncAV, a CRT software compatible with the company’s multiPoint pacing technology. The software was approved in the European market in June 2016.

Some of the key players in the market are Medtronic; BIOTRONIK, Inc.; Boston Scientific Corporation; St. Jude Medical; ZOLL Medical Corporation; MEDICO S.p.A.; Vitatron; Pacetronix; and Cordis, Inc. among others.

Recent Developments

• A newbattery-less, wireless pacemaker was introduced over the summer by researchers from Rice University. It is designed to harvest energy wirelessly from radio-frequency radiation transmitted by an external battery pack. The device was designed to be implanted directly into a patient’s heart, removing the need for wires, known as “leads,” which can create complications with bleeding and infection.
• A team of engineers out of the University of Texas at San Antonio (UTSA) announced in May a new grant from the National Science Foundationto commercialize a new chip that can make lower power electronics like cell phone batteries and pacemaker devices run more efficiently.
• Alain Nogaret & his team from BATH University has developed physical models and small devices capable enough to predicting neuron behavior and reversing the effect of heart failure. This gives way for development of new line of pacemakers
• Researchers from Harvard’s school of engineering and applied sciences have created the world’s smallest radio receiver, a technology assembled from atomic-scale defects in pink diamonds. It could have the potential to help power the next generation of wireless pacemaker devices by transmitting electrical pulses without the need for leads.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global complementary and alternative medicine market size is projected to reach USD 296.3 billion by 2027, exhibiting a CAGR of 19.9%, according to a new report by Grand View Research, Inc. A comparatively high demand for alternative medicine across developing countries and expanding applications of traditional medicine practiced in Asia are two key driving factors of the market. China and India are the key contributors to the Asia Pacific region and thus are offering significant momentum to the revenue generation by complementary and alternative treatment through the study period.

Inhale the future, exhale the past

So goes a saying in yoga, which means to embrace the present and what’s about to come, and leave the past behind and every baggage that came with it. It goes without saying that Yoga has widely come to be integrated into many a person’s daily routine, crossing the boundaries of both region, and religion. However, it is not only yoga that has captured the attention of the global citizen. Tai-chi, homeopathy, Ayurveda and reiki are some of the other phenomenon that have caught the world by storm. Exactly what are they, and how have they managed to convince people to practice them?

To answer simply, they are all forms that come under the concept of Complementary and Alternative Medicines (CAM). The next question would be, what exactly is this ‘CAM’? Simply put, complementary and alternative treatment include a number of traditional medicinal treatments where a disease is attended to with the help of organic products, natural methods, and faith healing. They are generally used in the treatment of chronic ailments and pains.

Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.

CAM - On A Blazing Trail…

Most prominent forms of complementary and alternative medicine in usage include application of ayurvedic medicine and naturopathic treatment, acupuncture, mind/body healing, yoga and magnetic intervention. Ayurveda and Naturopathic treatment involves usage of nature derived products that are believed to possess therapeutic properties for various medical conditions. Although the various forms of alternative medicine seem to be viable treatment options, they seldom have any documented and/or approved backing from any clinical data, and work on word-of-mouth and personal faith.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/complementary-alternative-medicine-market/request/rs1

The complementary and alternative medicine market has been classified according to the medium of their application, that is, whether they are traditionally used, or body healing, external energy, mind healing, or through the use of diet and herbs. Another form of treatment is through the senses.

• Traditional complementary and alternative medicine- Includes therapies and practices that have been practiced for centuries, and are more mainstream as compared to other CAM types. Examples are acupuncture, Ayurveda, homeopathy, naturopathy, and Chinese or Oriental medicine. 
• Body healing- Is based on the idea that injury or illness in one area of the body adversely affects other bodily functions. Steps involve the use of manual manipulation so that the other body parts can be brought back to their normal functioning, which would allow full focus on the actual site of injury or illness. Often, body healing techniques are combined with those of the mind. Examples of this type include massage, tai chi, yoga, body movement therapies, and chiropractic & osteopathic medicine.
• Diets and herbs- Today’s society is plagued with health issues on account of the shift towards food substances that are rich in oils, fats and complex carbohydrates. Previously, a person’s diet simply consisted of fruits, meat, vegetables and grains, which provided high nutritional value to the body. That is why this complementary and alternative medicine technique is making a big return, especially among the current working population who really need to maintain their physique and health. The approach includes herbal medicines, dietary supplements and nutrition/diet.
• External Energy- It is an age-old ad popular belief that external energies from various sources have a direct bearing on a person’s health. Techniques such as electromagnetic therapy, Reiki and Qigong help in quietening the mind and removing and releasing the blocked energies, thus helping the body, mind and spirit to reach balance and harmony.
• Mind- A healthy mind resides in a healthy body, it is said. There’s no better way to put forth the dependence that one has on other. This is even recognized by conventional science, and studies have proved that the healing process is faster and smoother if a person has positive emotional and mental health. Meditation, biofeedback and hypnosis are some of the techniques that are involved in the exercise of the mind.
• Senses- A relatively different approach in the complementary and alternative medicine market that makes use of art, dance and music forms, as well as visualization and guided imagery, to improve overall health. This technique makes use of the five human senses of touch, sight, hearing, taste and smell.

The global complementary and alternative medicine market size was projected at USD 69.2 billion in 2020, registering a CAGR of 19.9% over the forecast period. Yoga, meditation, magnetic intervention, acupuncture, and complementary wellness treatments are gaining immense popularity across developed countries. This can be attributed to wide acceptance of these alternative treatments among general population, further causing an upswing in the number of yoga studios, meditation centers, spas, and complementary wellness facilities.

Browse Press Release of this report:

https://www.grandviewresearch.com/press-release/global-alternative-complementary-medicine-therapies-market

Alternative Medicine and Advancements

These treatment forms have a history that dates a long way back into time and a number of them have documented origins in key Asia Pacific countries like India, China, and Japan. The techniques were limited to Asian countries for a considerable amount of time; however, they have rapidly gained popularity almost all over the world. Earlier, the practitioners of complementary and alternative medicines were considered as quacks; however, now it is rapidly being recognized across the globe as a genuine practice, with licensing being applied in this space.

A study by the National Center for Health Statistics (NCHS) and the NCCIH in 2017 found that in the United States:

• Adults showed an increase in the usage of complementary health practices, when compared to 2017.
• Yoga, meditation and chiropractorvisits all witnessed a rise in these five years, with meditation showing a three-fold increase from 4.1% in 2012 to 14.2% in 2017.
• Gender-wise, all of these alternative complementary and alternative medicine approaches have seen a higher acceptance in the female population of the country, with yoga showing the highest disparity in terms of percentage adoption in males and females (6% for males vs. 19.8% for females).

Alternative medicines have seen both support and opposition in every country. Several governments are taking steps to introduce alternative medicine as legal form to improve lives of people. For instance, the government of India launched the “AYUSH” ministry in 2014 that is expected to support and develop alternative forms of medicine and improve the medical tourism in the field of alternative medicine. The department saw huge allocation of funds in the 2017-18 budget, to the tune of ₹ 1428.7 crore. Several scientific bodies are striving to develop scientific support for the claims made by naturalists and followers claiming the medical effects of complementary and alternative medicine.

There have also been many incidents where complementary and alternative medicine practices have been used illegally, as in a recent case of a practitioner in the U.S. state of Virginia who was caught practicing without a license, leading to him being sentenced to 12 months in jail. Also, with the growing threat of coronavirus, there has been a boom in the number of false claims about alternative medicines helping in combating the virus without any substantiated proof, which is harming the image of genuine complementary and alternative medicine practices.

Complementary And Alternative Medicine: Market Snapshot

A recent report by Grand View Research has projected the complementary and alternative medicine market to be worth USD 296.3 billion by 2027, progressing at an astonishing CAGR of almost 20%. The key drivers impacting the growth of this industry include:

• Increasing adoption of alternative medicine across developing countries
• China and India have heavily contributed to the growth of the Asia Pacific region, and are expected to continue generating major revenue
• A rapid rise in the number of trained physicians in complementary and alternative medicine space is expected to shift patient preference towards these forms of treatment
• Integration of technological advancements
• Government initiatives to improve and provide scientific back-up

We have segmented the Complementary And Alternative Medicine market based on intervention type for which it is used:

• Botanicals (Ayurveda, Naturopathy and Homeopathy), Acupuncture, Mind, Body & Yoga and Magnetic Intervention. Botanicals held a significant share in 2020 and are likely to grow at a steady CAGR over the forecast years, while magnetic intervention has been projected to show fastest growth through 2027.
• The market is also segmented on the basis of distribution channels, into direct sales, e-sales and distance correspondence, wherein direct sales have dominated with almost three-quarters of the market share.

Some of the major complementary and alternative medicine market players include Nordic Nutraceuticals, Columbia Nutritional, Ramamani Iyengar Memorial Yoga Institute, Herb Pharm, John Schumacher Unity Woods Yoga Centre, Pure Encapsulations, LLC., The Healing Company Ltd, AYUSH Ayurvedic Pte Ltd, and Sheng Chang Pharmaceutical Company.

• The U.S. state of Los Angelessaw a listing platform called “WellSet” being launched in March 2020, which caters to the alternative and holistic healthcare market. The service makes it easy for customers to find acupuncturists, therapists, nutritionists, life coaches and the likes for their line of complementary and alternative medicine treatment.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global clinical laboratory tests market size is expected to reach USD 304.9 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.1% over the forecast period. Introduction of new solutions for minimizing errors and maximizing efficiency is anticipated to boost the overall market growth.

I believe that the greatest gift you can give your family and the world is a healthy you - Joyce Meyer

Health is and will always be considered as the most important wealth a person can have. Good health makes a person fully capable of enjoying every wonderful moment of his or her beautiful life. However, it’s also a truth that people fall sick and get bereaved of some of those beautiful moments of their lives. Sickness and ill health takes a large toll on people’s lives, quite evident from the COVID-19 pandemic. In these times, healthcare facilities like clinical laboratory testing boost the doctor’s ability to help the patients.

The most common concern for the governments of all Covid-19 hit nations is the excruciating need to screen for and test large numbers of patients for possible Sars-Cov-2 infection. As a result, most of them are facing major shortages in the supply for diagnostic kits to test for the virus. Diagnostics virology entities are under immense pressure to provide reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across a large number of countries. The report will account for Covid19 as a key market contributor.

Clinical Tests: The Base For Diagnosis And Prevention Of Fatal Disorders

Clinical laboratory tests form an integral part of the healthcare industry, as approximately 80% of diagnoses by healthcare professionals are laboratory-based. The shortened length-of-stay at hospitals and reduced contact between a patient and the concerned physician has increased the demand of clinical laboratories. Rising demand for early detection, especially for gynecological, oncological, and endocrinological diseases, is expected to drive Clinical Laboratory Tests Market growth, such that from its market size of USD 176.7 billion in 2020, it is expected to grow to USD 304.9 billion by 2027 at a CAGR of 7.1%, according to a new report by Grand View Research, Inc. Other drivers are growing global geriatric population base and the introduction of various innovative solutions.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/clinical-laboratory-tests-market/request/rs1

Importance Of Clinical Tests In Healthcare

Clinical laboratory tests are a set of individual and panel of tests for diagnosis of various diseases occurring due to irregular cell count, electrolyte deficiency, dyslipidemia, and chemical imbalance. A wide range of clinical tests that provide medical practitioners with the ability to detect disease progression include blood and urine tests ranging from simple to complex, and various medical chemistry panels to molecular expression genetic analysis.

A global increase in the demand for clinical laboratory tests is a direct consequence of the need by medical fraternity to gather and process patient-related medical information for use by physicians and healthcare providers, to impart accurate preventive measures and treatments. Hence, clinical tests are an indispensable part of all medical diagnostic techniques and almost all medical diagnoses are dependent on the results of clinical laboratory tests.

One Panel For Many Applications

The Basic Metabolic Panel (BMP) is a bundle of seven or eight blood tests, which provides information about the body's metabolism. It provides key information regarding kidney functioning, electrolyte status, blood sugar level, and response to medications. This panel also helps in finding the blood level of calcium, blood urea nitrogen, chloride, carbon dioxide, creatinine, potassium, glucose, and sodium.

On the contrary, Comprehensive Metabolic Panel (CMP) includes tests such as kidney function assessment, protein test, and liver function assessment, in addition to BMP. Hence, depending on the need of diagnosis, a medical practitioner can ask for CMP, a group of 14 tests inclusive of BMP.

Rising blood cholesterol levels amongst adults and a consequential increase in the body disorders caused by abnormal lipid levels and cardiac problems is the major factor contributing to the growth of lipid panel. Moreover, rapidly increasing penetration of lipid diagnostic tests in the emerging Asia Pacific and Latin American markets is expected to drive growth during the forecast period.

Lucrative Competitive Landscape

The global clinical laboratory tests market is dominated by key market players like  Abbott; ARUP Laboratories; OPKO Health, Inc.; Bioscientia Institut für Medizinische Diagnostik GmbH; Charles River; NeoGenomics Laboratories, Inc.; Genoptix, Inc.; Healthscope Ltd.; Labco; Laboratory Corporation of America Holdings (LabCorp); Fresenius Medical Care; QIAGEN; Quest Diagnostics; Siemens Healthcare Private Limited; Tulip Diagnostics (P) Ltd.; Sonic Healthcare; Merck KgaA; and Biosino Bio-technology and Science Inc.. The companies are focused on mergers and acquisitions with an aim to enhance their product portfolio. For instance, Charles River acquired MPI research in 2018, a premier non-clinical contract research organization that provides comprehensive testing services to different biopharmaceutical and medical devices companies. Moreover, the companies are expanding geographically to cater to the clinical testing market. For instance, BioSino Bio-Technology & Science Inc. collaborated with Abbott to increase market penetration in Canada

Have A Query? Ask Our Experts:

https://www.grandviewresearch.com/inquiry/1300/ibb

Presence of favorable reimbursement plans for laboratory tests is anticipated to positively influence the global market. According to an article published in the American Clinical Laboratory Association (ACLA), these tests are reimbursed by Medicare payees either under the Physician Fee Schedule or Clinical Laboratory Fee Schedule based on the nature of service.

According to an article published in Forbes, in 2018, the new clinical lab fee schedule reduced their overall payments by 10% as compared to 2017 for tests that represent nearly two-thirds of Medicare’s outlays for laboratory tests.

In addition, growing demand for early detection of several diseases is anticipated to drive the clinical laboratory tests market over the forecast period. For instance, biochips are used for preparing thousands of DNA, RNA, or protein samples that can be processed on a single chip at the same time. According to an article published in the American Clinical Laboratory Association, more than 7 billion clinical laboratory examinations are performed each year in U.S.

Presence of major players such as QIAGEN, Laboratory Corporation of America Holdings, Siemens Healthcare GmbH, Quest Diagnostics Incorporated, and Abbott is expected to fuel the market growth. These companies are involved in undertaking initiatives such as product development, strategic collaborations, and regional expansion.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global sports medicine market size is projected to reach USD 15.2 billion by 2027, expanding at a CAGR of 8.2%, according to a new report by Grand View Research, Inc. The increasing demand for sports medicine, owing to the shift towards a healthy lifestyle adopted by the young population, and rising incidences of injuries among athletes and fitness enthusiasts are some of the major factors driving the market.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

Even athletes aren’t superhuman, as many of us believed in our childhood. What helps them get back from injury faster is the availability of sophisticated and advanced sports medicines

You might have heard sportspersons saying, “I would not miss this match for my life!” Well, what would happen if this match is just a couple of weeks or a month away, and this sportsperson gets injured? Straight to the doctor’s table he goes, where the whole fitness team tries to get him/her ready for the game. Today, the expansion in research and technology fields is so rapid that medicines are witnessing a revolutionary development each day, and more so in the field of games and sports. Popular global sports such as soccer, football, basketball and cricket, all carry high risk of injuries to players from time to time, and the present-day medicines aim to help them recover and recuperate in the shortest possible time.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/sports-medicine-industry/request/rs1

Sports medicine is an area dealing with physical fitness, and the prevention and treatment of injuries concerning exercise and sports. Team sports have seen the emergence of various types of medical experts working with the management to handle multiple injuries. This may comprise of orthopedic surgeons, sports physical therapists, sports medicine primary care physicians, and physical medication and rehabilitation specialists.

With sporting events becoming a year-round phenomenon, there is massive pressure on athletes to keep performing day-in and day-out. Contact sports such as soccer, football and basketball all require athletes and sportspersons to perform at their peak, while the physicality exponentially increases the risk of them being at the receiving end of a serious injury. These factors are justifying the growth of the sports medicine market.

Some Stats To Understand The Need For The Sports Medicine Market…

According to the National Health Statistics Reports that gathered data for the period 2010-2016 in the United States, the emergency departments across the country witnessed 2.7 million visits by young people between the ages of 5-24, on account of sports injuries. The most frequent causes of these injuries were football (14.1%), basketball (12.5%), pedal cycling (9.9%), soccer (7.1%) and ice or roller skating or skateboarding (6.9%). Of these, 3 sports activities are team and contact-based (football, basketball and soccer).

According to a paper published in the Australian Journal of Science and Medicine in Sport published back in 2013, team athletics poses a higher risk of injury in comparison to individual sport. The ratio between the two was calculated to be 3:1.5. It also stated that the level of trauma was higher in case of team games, thereby requiring medical assistance. For instance, ice hockey, a team sport majorly causes head, neck and shoulder injuries in about 34 cases out of 100 times. This again underlines the importance of the sports medicine industry.

Kids And Teenagers Vying To Become The Next Big Thing In Sports

The participation of children is high in sports activities, on account of them trying to emulate their sporting idols. Michael Jordan, Cristiano Ronaldo, Roger Federer and Lionel Messi are some of the world-known athletes driving kids and youth towards adopting team or individual sports. Another major factor for the high adoption rate among kids and teenagers are the associated perks, such as:

• High remuneration
• Celebrity status and fame such as being immortalized through movies
• Presence of other sources of income such as endorsements
• Living healthy lifestyle and having access to best medical care

All these factors have led to the expansion of the sports medicine market, as the safety of kids becomes paramount. The market is inclusive of numerous medical equipment that are routinely utilized to address mild to severe injuries caused due to sports and other physical activity. The industry is expected to grow rapidly in the next few years owing to adoption of healthy lifestyle among the middle-aged and young population, wherein the adoption of workout sessions and sporting activities exposes them to the risk of sustaining injuries.

Have A Query? Ask Our Experts:

https://www.grandviewresearch.com/inquiry/173/covid

Which Products Are Used By Athletes?

Body reconstruction and repair devices formed the largest segment among sports medicine products in 2020, owing to their routine application in healthcare settings. These include devices such as implants of the anatomical part that has been damaged such as knee, shoulder, foot, hip and others. Other products include interference screws, clamps, fasteners, connecting bars, hinges, sockets, caps, and design frames. Broadly these have been classified and analyzed as surgical equipment devices, soft tissue repair devices, and bone reconstruction devices.

For the treatment of injuries, various sports medicine products have been developed over the past many years, which are broadly classified into:

• Body reconstruction and repair- Involves the treatment for damaged muscles, joints and tissues. Orthopedic surgery is performed on the musculoskeletal system. This sports medicine product segment surgical equipment, soft tissue repair devices and bone reconstruction devices.
• Body support and recovery- The products here help in properly supporting the structure of the affected portion, thus helping in its rapid recovery. Subsegments include braces and supporting devices, which are for commonly affected areas such as knee, ankles and wrists; compression clothing, which has been shown to improve both performance and recovery, as well as reduction in muscle inflammation and damage post-exercise; and hot and cold therapy, where the former helps in chronic injuries such as muscle strains, while the latter helps in reducing inflammation.
• Body monitoring and evaluation- These sports medicine products help to keep track of the improvements in the condition regarding the area of concern, such as cardiac functions, as well as respiratory, hemodynamic and musculoskeletal conditions.
• Accessories - Includes products required for topical application such as bandages and tapes, disinfectants and wraps.

Sports Medicines Help To Combat Injuries In Common And Key Areas…

The other parameter on the basis of which the sports medicine market is segmented includes application i.e. the site at which these devices will be used. These include:

• Shoulders- SLAP tear affects the cartilage ring that surrounds one’s shoulder socket, and is caused by repetitive overhead motions such as throwing baseball, playing tennis, or swimming. Shoulder instability occurs due to the lack of support for shoulder joints from ligaments, tendon and muscles. This results in the top part of the upper arm bone dislocating or subluxating. Another well-known injury is the rotator cuff injury, which leads to a weakened shoulder with reduced motion range.
• Knees- Injuries are caused either due to overuse, or due to impact or collision (acute injuries). Overuse injuries include patellofemoral pain syndrome, tendonitis or patellar tendinitis; while acute injuries include sprains and strains, and in serious cases, fractures or torn ligaments. This was the most dominant application segment regarding the sports medicine market in 2020.
• Ankle & foot- Some of the most well-known injuries are caused at the site of the foot and ankle, such as Achilles Tendinitis, which affects the Achilles tendon (the largest tendon in the body). Often occurs due to overuse and degeneration. Other known injuries include plantar fasciitis, stress fractures, ankle sprain, neuroma and heel spur.
• Back & spine- This application segment for sports medicine products include muscle strains and ligament sprains. Other injuries include spondylolysis and spondylolisthesis, as well as ‘stinger’, a nerve injury that occurs about the shoulder or neck.
• Elbow & wrist- With regards to elbow, the most common injuries include ligament injury and osteochondritis dissecans (OCD) capitellum. Wrist injuries include distal radius fracture, scaphoid fracture, tendonitis tendon instability and ligament injury.
• Hips- Most common hip injuries in athletes include muscle strains, hip bursitis, stress fracture, hip labral tear, sports hernias, snapping hip syndrome and hip arthritis.

Some Recent Developments

Some of the major players in the sports medicine market include Arthrex, Inc., Smith and Nephew, Stryker, Zimmer Biomet, Wright Group N.V., and DJO Global. Recent developments from these leading companies include:

• In September 2020, Zimmer Biometreceived FDA clearance for its JuggerStitch™ Meniscal Repair Device, paving way for its availability in the U.S. market. The device offers less-invasive, all-suture, knotless approach to meniscal repair procedures.
• In September 2020, Arthrexlaunched the InternalBrace™ Ligament Augmentation for the thumb ulnar collateral ligament (UCL) tear, which is a common injury in baseball, hockey and basketball. The product offers additional strength during surgery, as well as during the healing period.
• In March 2020, Strykerannounced its acquisition of OrthoSpace Ltd., and its InSpace rotator cuff repair device. The device is a biodegradable sub-acromial spacer that has been designed to realign the shoulder’s natural biomechanics.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global biotechnology market size is expected to reach USD 727.1 billion by 2025, at a CAGR of 7.4% according to a new report by Grand View Research, Inc. The emergence of certain key themes in the market is expected to drive growth in this industry to a lucrative extent.

Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.

Buddha is quoted as saying that “and everybody knows that a growling engine of change in modern age is – Technology. It has the potential to build upon existing systems or completely overthrow redundant tech and substitute them with a modern efficient technology. Biotechnology is one of the shining examples of this phenomenon and will continue to be so until a long time.

What Exactly is Biotechnology?

‘Biotechnology’ is the broad area of biology, involving living systems and organisms and deals with biological processing of those living organisms & systems to develop new technologies. It also exploits cellular & biomolecular processes to create new products & technologies. This leads to improvement in the health of consumers and the planet boosting the growth of Biotechnology market. Along with many things, it also deals with Tissue engineering, DNA sequencing and Nanobiotechnology.

Biotechnology covers broad aspects in the utility arena. Although, it is used in several field, its apt usage is in four sectors, namely, Health care (Medical), Crop production and Agriculture, Non-food (Industrial) uses of crops and other products (e.g. biodegradable plastics, vegetable oil, biofuels), and Environmental uses.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/biotechnology-market/request/rs1

For example, one application of biotechnology is the directed use of microorganisms for the manufacture of organic products (examples include beer and milk products). Another example is using naturally present bacteria by the mining industry in bioleaching. Biotechnology is also used to recycle, treat waste, clean-up sites contaminated by industrial activities (bioremediation), and also to produce biological weapons.

Its Role

Biotechnology is rooted in the science of microbiology, genetics, animal cell culture, embryology, cell biology, etc. The technology provides breakthroughs, developments, and products in biofuels, agricultural biotechnology, regenerative medicines, vaccines, and so on.

Biologists study cell functions & structure to get a better understanding of proteins, genes, and cells. The same helps fight orphan diseases, reduces carbon footprints, and provides cleaner energy. In addition, products developed from the technology boosts food sources, combats pollution, and improves nutritional health.

Further key findings from the report suggest:

• Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period
• Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the biotechnology market
• Decreasing costs and rise in number of services in this segment are expected to drive segment with lucrative avenues
• North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in larger share
• Introduction of technologically advanced products and presence of various biotechnology based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are attributive to drive the growth of sector in the coming years
• Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products
• Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in area of regenerative medicine
• Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza

The global biotechnology market size is expected to reach USD 727.1 billion by 2025, at a CAGR of 7.4% according to a new report by Grand View Research, Inc. The emergence of certain key themes in the market is expected to drive growth in this industry to a lucrative extent.

These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases, while recommending clinical trials.

Have a Query? Ask our experts:

https://www.grandviewresearch.com/inquiry/369/ibb

Its role in following sectors is quite prominent.

• Healthcare (Medical): Biotechnology has been leveraged by the R&D professionals to bring more efficiency to medical practice and invade into arenas untouched by medicine. Technologies like Bioinformatics, Nanobiotechnology and DNA sequencingamong others, has been of a big help. For example, Biotechnology has contributed to the discovery and manufacturing of traditional small molecule pharmaceutical drugs as well as drugs that are the product of biotechnology –  Modern biotechnology can also be used to manufacture existing medicines relatively easily and cheaply.

When it comes to health, genetic modification by biotechnology is also something to be highlighted. It has been applied in modifying the genetic structure of Mosquitoes (GM), resulting in the increase of capability to fight the outbreaks of harmful vector-borne diseases like Zika, Dengue and Malaria etc.

• Crop production and Agriculture: Genetically Modified (GM) crops are developed with the help of biotechnology and has proved its worth in raising the yield of crops in the countries battling hunger and poverty. For example, Countries; like Burkina Faso, Nigeria, Egypt, South Africa, and Sudan are cultivating genetically engineered crops; such as Bacillus thuringiensis (Bt)cotton, corn, cow pea, nitrogen, water efficient rice, etc. Apart from this, scientists have also developed 3-D printed biotechnological CellPods that incubate seeds and accelerate their growth (with the help of adequate sunlight, air, & nutrition).
• Non-Food (Industrial) Uses: Biotechnology is used in industries worldwide to develop several products, i.e.textile, fermented food products, paper and pulp, detergents as well as chemicals among others. Also, Genetically Modified Organisms (GMOs)

have been developed to enhance the diversity of applications and economic viability of industrial biotechnology.

Nowadays to alleviate the problems of growing plastic waste, Biotechnology is also being leveraged to develop biodegradable plastics. This provides a huge push to the climate change initiative.

• Environmental Uses:- With growing concerns regarding the environment nowadays, countries are looking towards biotechnology for new developments and remedies and biotechnology answers! Bioremediation is a fine example of leveraging biological organisms to treat waste and oil spillage in the seas and oceans.

How is the market faring?

The global biotechnology market size is expected to reach USD 727.1 billion by 2025, at a CAGR of 7.4%. This shows the amount of potential this market has in the current time. The key players in the markets are putting pedal to the metal and investing heavily to cater to the growing need of biotechnological demands.

Key players are Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Pfizer, Merck & Co., and Sanofi among others. Mergers, collaborations, and manufacturing activities are the key strategies adopted by them to gain shares.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global position sensors market is expected to reach USD 9.93 billion by 2022, according to a new report by Grand View Research, Inc. Increasing demand for electronics and sensor systems in automobiles is expected to augment demand. Factors such as the need for contactless technologies, requirement for lower CO2 emissions, and improvement in reliability and precision are expected to trigger demand over the forecast period.

The recent COVID-19 pandemic that has been ravaging numerous countries across the globe has adversely affected the overall sensor, control, and automation industry. While the capital investments in the automation sector have been lethargic before the pandemic, they are expected to be put on hold or postponed for at least a year. However, the recent standstill in industrial manufacturing and production is anticipated to act as a wake-up call for the manufacturing sector on its reliance on human labor. This, in turn, is expected to highlight the advantages of robotics and automation helping a greater adoption in the post-pandemic period. As IoT, industrial automation, and digitalization are expected to become increasingly relevant to post-pandemic Tier 1 manufacturers, it may eventually turn into an opportunity especially in evolving supply chains. The report will account for Covid19 as a key market contributor.

Increasing requirement of accurate sensor performance for detection of reflective objects and signaling the position of moving components in semiconductor and electronics industry is expected to boost the sensor demand over next seven years.

Increased awareness regarding vehicle safety and technological advancements are anticipated to drive the global demand for position sensor market. Escalating demand for navigation and GPS-enabled wearable devices and smartphones is expected to further entice growth.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/position-sensors-market/request/rs1

Growing requirement of time-proven positioning sensing technology and highly customized solutions for mission critical needs in military and aerospace applications is anticipated to augment the demand for these sensors. Stringent vehicle emission regulations in several countries worldwide are encouraging the adoption across various verticals.

However, lack of product differentiation is expected to challenge industry growth. A large number of players offer products based on similar technological foundation. This propels industry players to compete with large manufacturers for high-volume contracts and is thus exposed to corresponding pricing pressure.

Further key findings from the report suggest:

• Proximity sensor was valued at over USD 1.5 billion in 2014 and is expected to remain a major segment over the next seven years. Applications of proximity sensors include position, detection, inspection, and counting on automated machines and manufacturing systems. They are also used in machine vibration monitoring to measure variations in distance between a shaft and its support bearing.
• Photoelectric sensors industry is expected to grow at a CAGR of 5.8% from 2015 to 2022 owing to increased adoption of automation in process, automotive, and food & beverage industries
• Packaging application is expected to grow at a CAGR of 7.0% from 2015 to 2022. This can be primarily attributed to increasing adoption of sensors in automation to improve performance and reliability. Position sensors in packaging are used for monitoring the position of a moving machine part, detecting the location of label applicator, and end point detection of mechanical part.
• The Asia Pacific position sensors industry is expected to remain the largest owing to strong demand for high quality precision equipment and consumer electronics demand. The regional industry is expected to account for over 40% by 2022, growing at a CAGR of over 6.0% from 2015 to 2022.
• Key players in the position sensor market include Honeywell International, Inc., Sick AG, Allegro Microsystems, iFM Elector Inc., Heidenhain, Keyence Corporation, Bourns, Inc., Schneider Electric, Siemens AG, Vishay Intertechnology, Inc., Banner Engineering, Balluff GmbH, and Sensata Technologies.

In this price sensitive market, it has been a difficult task for these manufacturers to differentiate their products with any factor other than price. Extensive R&D investment in order to obtain competitive advantage is also expected to result in frequent strategic alliances and acquisitions.

The global position sensors market was valued at USD 6.83 billion in 2014. Growing adoption of integrated control systems in consumer electronics devices such as smartphones and tablets is expected to offer lucrative growth opportunities over the forecast period. The emerging trend towards plant automation in process industries is generating high demand for position sensors. Stringent emission laws legislated in various European countries are encouraging the use of linear and rotary position sensors. These sensors play a crucial role in ensuring vehicle compliance with the slated emission riders.

Have any Query? Ask our Experts:

https://www.grandviewresearch.com/inquiry/2804/ibb

Grand View Research has segmented the position sensors market on the basis of technology, application:

Position Sensors Technology Outlook (Revenue, USD Million, 2012 - 2022)

• Photoelectric
• Linear
• Proximity
• Rotary
• Others

Position Sensors Application Outlook (Revenue, USD Million, 2012 - 2022)

• Automotive
• Military & Aerospace
• Electronics & Semiconductors
• Packaging
• Others

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global dashboard camera market size is expected to reach around USD 7.5 billion by 2027, exhibiting a 12.9% CAGR during the forecast period, according to a new report by Grand View Research, Inc. As per research findings, an estimated 36.1 million dashboard cameras were sold in 2020. Implementation of several favorable government regulations to boost the adoption of dashboard cameras, coupled with the increasing awareness among the population worldwide regarding vehicular safety, is driving the global market.

The automotive & transportation industry is amongst the most exposed verticals to the ongoing COVID-19 outbreak and is currently amidst unprecedented uncertainty. COVID-19 is expected to have a significant impact on the supply chain and product demand in the automotive sector. The industry's concern has moved on from being centered on supply chain disruption from China to the overall slump in demand for automotive products. The demand for commercial vehicles is expected to plummet with the shutdown of all non-essential services. Furthermore, changes in consumer buying behavior owing to uncertainty surrounding the pandemic may have serious implications on the near future growth of the industry. Meanwhile, liquidity shortfall and cash crunch have already impacted the sales of fleet operators, which is further expected to widen over the next few months. We are continuously monitoring the COVID-19 pandemic, and assessing its impact on the growth of the automotive & transportation industry. The report will account for Covid19 as a key market contributor.

There has been an increasing awareness regarding the benefits of dashboard cameras among the motorists worldwide due to frequent news videotapes of road crashes and accidents captured by the dashboard cameras. Moreover, the use of dashcams is being encouraged by the governments in several European countries such as U.K., France, and Italy, to record footages for surveillance purposes that can be later used as evidence in the legal proceedings.

The use of dashcams is increasing in the trucking industry; as increasing number of drivers and fleet owners are installing dashcams to harness the numerous benefits they offer. With easy installation and improved technology, dashboard cameras have now enabled the commercial fleet companies to safeguard their vehicles. Enhancement of driver coaching programs, the ability to see what happens during a critical incident, and improvements in overall fleet safety are some of the prime motivators for the rising installation of dashboard cameras.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/dashboard-camera-market/request/rs1/

The prominent industry participants have started developing innovative car Digital Video Recorders (DVRs) with sophisticated safety features, such as blind-spot detection, collision avoidance systems, voice reminders, and lane departure warning systems, to encourage their adoption among individual as well as commercial vehicle drivers and owners. Some manufacturers have also started providing Wi-Fi enabled dashboard cameras, wherein users can transfer footages to their smartphones using mobile applications.

Dashboard Camera Market Report Highlights

• Europe and North America are characterized by the rapid adoption of Full HD and 4K dashboard cameras. The growing replacement of SD and HD dashboard cameras with its advanced counterparts is expected to drive the adoption of high-resolution dashboard cameras over the forecast period
• Commercial fleet operators are increasingly adopting rearview dashcams to seek additional protection in the event of an accident and against cases of employee fraud
• The personal vehicle segment is expected to account for approximately 65% of the overall market share in 2020 and is projected to emerge as the fastest-growing segment over the forecast period
• Asia is anticipated to emerge as the global manufacturing hub for dashboard cameras. Cheap labor, and concentrated presence of dashcam manufacturers and their facilities in the Asian countries, such as China and Taiwan, are expected to offer numerous opportunities for the global manufacturers to relocate their supply chains in the region
• Key Players include in the dashboard camera market are ABEO Technology; Garmin Ltd.; Pittasoft Co. Ltd.; Falcon Zero LLC, Panasonic Corporation; Cobra Electronics Co., and DOD Tech

The global dashboard camera market size was valued at USD 2.8 billion in 2020, with an estimated 36.1 million units of dashboard cameras sold in the same year. The industry is expected to witness an increase in the demand for installation of such cameras in commercial and passenger vehicles owing to the rise in sales of new vehicles. Rising demand for vehicular safety and favorable government initiatives are some key factors, expected to fuel the market growth.

Growing inclination of motorists toward the usage of such cameras to seek added legal protection in case of road mishaps and accidents is expected to drive the demand for dashboard cameras worldwide. Frequent news occurrences showing the footage of crashes and road accidents captured by such devices has significantly helped to increase general public awareness regarding the benefits of car DVRs.

Dashboard cameras are increasingly becoming popular with drivers across the globe. This technology is finding home in many commercial as well as personal vehicles, as it empowers the driver to take control of on-road security and allows to record incidents such as collisions, theft, and vandalism. The camera footages obtained from dashboard cameras are now being accepted for proving liability and insurance claims. Insurance companies are promoting the adoption of dashboard cameras by providing discounts on insurance premiums with the aim to fight against false insurance claims.

Have any Query? Ask our Experts:

https://www.grandviewresearch.com/inquiry/2809/ibb

Some insurance companies are offering customers up to 15% of discount on monthly premiums for using dashboard cameras in their vehicles. This has significantly increased the popularity of dashcams across the world. Adoption of dashcams is expected to soar in the North American region over the forecast period. In January 2017, New York (NY) State proposed a Senate Bill (S438), under which the non-commercial vehicle owners will get approximately 5% discount on premium for using a dash cam.

The key manufacturers are focusing on integrating dashcams with advanced interactive features and differentiation of products, thereby augmenting the basic utility of video recording. ABEO Technology; Garmin Ltd.; Pittasoft Co. Ltd.; Falcon Zero LLC, Panasonic Corporation; Cobra Electronics Co., and DOD Tech are some of the market incumbents.

Grand View Research has segmented the global dashboard camera market by technology, product, video quality, application, distribution channel:

Dashboard Camera Technology Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2027)

• Basic
• Advanced
• Smart

Dashboard Camera Product Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2027)

• 1-Channel
• 2-Channel
• Rear View

Dashboard Camera Video Quality Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2027)

• SD & HD
• Full HD & 4K

Dashboard Camera Application Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2027)

• Commercial Vehicle
• Personal Vehicle

Dashboard Camera Distribution Channel Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2027)

• Online
• In-Store

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global automotive tire market size is expected to reach USD 374.22 billion by 2024 according to a new report by Grand View Research, Inc. increasing automotive sales especially in countries such as China, India, Japan, and South Korea is anticipated to favorably impact the global automotive tire market over the forecast period. This growth can be attributed to rising disposable income and improvement in the overall lifestyle of consumers.

The automotive & transportation industry is amongst the most exposed verticals to the ongoing COVID-19 outbreak and is currently amidst unprecedented uncertainty. COVID-19 is expected to have a significant impact on the supply chain and product demand in the automotive sector. The industry's concern has moved on from being centered on supply chain disruption from China to the overall slump in demand for automotive products. The demand for commercial vehicles is expected to plummet with the shutdown of all non-essential services. Furthermore, changes in consumer buying behavior owing to uncertainty surrounding the pandemic may have serious implications on the near future growth of the industry. Meanwhile, liquidity shortfall and cash crunch have already impacted the sales of fleet operators, which is further expected to widen over the next few months. We are continuously monitoring the COVID-19 pandemic, and assessing its impact on the growth of the automotive & transportation industry. The report will account for Covid19 as a key market contributor.

Technological proliferation and the development of the innovative and environment-friendly green tires have opened up broad growth avenues for the industry participants. Moreover, increasing radial tire up gradation activities owing to its benefits such lesser vibrations, reduced fuel consumption and extended tire life due to less heat generated has favorably impacted the industry growth.

However, stringent emission norms by governments and regulatory authorities worldwide are expected to challenge demand. For example, on September 1, 2010, the California Air Resources Board’s (ARB’s) Tire Pressure Regulation was formulated to reduce greenhouse gas emissions from vehicles operating with underneath inflated tires by inflating them to the suggested pressure rating.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/automotive-tire-market/request/rs1

Further key findings from the report suggest:

• Two wheelers segment is anticipated to grow at CAGR of over 7.5% from 2016-2024. Increasing demand for two-wheelers across the developing countries such as India and China will contribute to the segment growth.
• Increasing manufacturing and infrastructure building activities have spurred the sales of light commercial vehicles (LCV). Growing number of LCVs in Europe has led EU regulatory bodies and OEMs to enhance and improve the safety aspects of LCVs. The passenger car segment dominated the industry with over 40% revenue share in 2015 owing to the increasing advancements and innovations such as Plug-in cars.
• The tire industry has witnessed a remarkable shift from the traditional to the technically advanced radial products. Radialisation of the truck tire market is anticipated to fuel the demand over the forecast period. In 2012, manufacturers in China produced over 50% of the global radial truck tires industry.
• Stringent government guidelines worldwide are expected to regulate the global automotive tire market over the coming years. Asia Pacific dominated the industry contributing to over 40% of the global revenue in 2015. The presence of several prominent automobile manufacturers and ancillaries in the region is expected to generate high demand over the forecast period.
• Key industry participants include Bridgestone, Continental, Goodyear, Michelin, Pirelli and Sumitomo. Manufacturers are gradually adopting innovative production techniques to gain a competitive advantage over others. Vendors are now adopting modern supply chain and distribution strategies such as e-commerce and retail chains to reach efficiently the end-user apart from the conventional supply to automobile assemblers and aftermarket industry.

The global automotive tire market size was valued at USD 227.7 billion in 2015. Technological advancements across the industry are expected to spur the demand over the forecast period. Companies in the automotive tire space continuously focus on product differentiation by offering innovative technologies due to the competitive nature of the industry. The technology offers high levels of performance and durability, for example, the tread pattern self-regenerates as it is used, which means it can deliver a high level of grip even when worn.

Increasing sales for passenger and commercial vehicles across the globe is anticipated to drive the consumption for tires over the future. According to the OICA, the International Organization of Motor Vehicle Manufacturers, over 90 million new passenger and commercial vehicles were manufactured in the year 2015, registering a cumulative growth of over 1.1% over the previous years’ production. In Europe, over 17 million motor vehicles were manufactured, that was around 19% of the overall global production, which has led to an increase in demand for automotive tires.

Tire manufacturers are increasingly interested in developing sustainable tires that are not only cost effective and meet scrupulous performance standards. For example, Lehigh Technologies offer Micronized Rubber Powder (MRP), which are low-cost, sustainable, customizable and high-performing feedstock for manufacturing that has been used in over 300 million tires.

Increasing adoption of Low Rolling Resistance (LRR) and self-inflating technology by manufacturers owing to the increasing awareness regarding the fuel efficiency is projected to drive the demand. LRR tires reduce wasted energy and decline the required rolling effort. Increasing pressure to improve fuel mileage has forced all of the manufacturers to adopt these tires.

Have any Query? Ask our Experts:

https://www.grandviewresearch.com/inquiry/2862/ibb

Grand View Research has segmented the global automotive tire market on the basis of application, type:

Automotive Tire Application Outlook (Revenue, USD Billion, 2014 - 2024)

• Passenger cars
• LCV
• HCV
• Two wheelers

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global 4K Set-top Box (STB) market size is projected to reach USD 7.18 billion by 2024, as per a new report by Grand View Research, Inc. The growing inclination of the global public towards ultra-high definition video viewing can be attributed as a major reason for the 4K STB market growth.

Media consumption is expected to witness a substantial increase as a direct consequence of lockdowns enforced in several countries across the globe to combat the spread of the deadly coronavirus. Since consumers are forced to stay at home, they are turning to popular OTT service providers such as Netflix, Amazon Prime, etc. or renewing/enhancing their existing Pay TV packages, procuring IPTV subscriptions, etc. to satiate their entertainment needs. eSports is also another sector which is expected to be favorably impacted by more and more people confined to their homes. The report will account for Covid19 as a key market contributor.

The demand for media-rich home entertainment services among consumers is increasing and is anticipated to fuel market growth. The growth is further fostered by favorable government initiatives, large-scale digitization programs, and mandatory installation of set top boxes. Improved standard of living owing to increased purchasing power is positively impacting the industry growth.

The initiatives undertaken by the Federal Communications Commission for supporting third party STB manufacturers is paving the way for the expansion of the Ultra High-Definition (UHD) STB industry. The market is anticipated to gain traction in Asia Pacific owing to the strong presence of low-cost set top box manufacturers, especially in countries such as Korea, Taiwan, and China.

The increasing penetration of 3D and 4K TVs and escalating demand for large screen displays are fueling the demand for Ultra High-Definition (UHD) STBs. Smart features such as STB operability through voice commands given by Remote Control Unit (RCU) is garnering high potential. The computational capabilities of STBs in combination with the advent of quality standards to satiate growing customer expectations have culminated in the STB market growth.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/4k-set-top-box-market/request/rs1

Further key findings from the report suggest:

• Internet Protocol Television (IPTV) 4K STBs accounted for over 20% of the market share in 2015 and are expected to witness considerable growth over the forecast period. Increasing broadband penetration can be attributed as the major reason for the rise in the market share of IPTV 4K Set-top Box devices. The IPTV set top box product segment is projected to gain traction owing to benefits such as integration of TV, PC, home phone, and wireless devices offering a high quality of viewing experience to the end-users.
• The Asia Pacific 4K STB market was valued at over just over USD 50 million in 2015 and is projected to witness high growth over the next eight years. India is poised to emerge as a lucrative market for UHD STBs with the country expected to witness a CAGR substantially higher than the regional average. Several DTH operators such as Tata Sky, Videocon, and Airtel have launched UHD STBs and are attempting to achieve a higher rural penetration with affordable regional packages.
• Key industry participants include ZTE Corporation, SAGEMCOM, Arion Technology, Roku Inc., and Infomir LLC. Manufacturers are emphasizing on UHD STBs incorporated with interactive 4K content to gain a competitive edge in the industry.
• Technology giants such as Apple Inc. have managed to make their mark in this competitive industry. The Apple TV device aids the streaming of (Over-The-Top) OTT content and other videos over the internet. The launch of advanced OTT devices such as Google Inc.’s Chromecast media streaming device and Amazon’s Fire TV STBs have opened up new avenues in the industry.

Eagerness to exploit the full capabilities of 4K TVs have driven market growth

The global 4K Set Top Box (STB) market size was valued at USD 218.4 million in 2015. Growing emphasis on crystal-clear broadcast quality and eagerness to exploit the full capabilities of 4K televisions have helped 4K STBs make steady inroads into the niche economic class. Growing demand for high-quality in-home entertainment is expected to be the key factor responsible for modern day consumers shifting their preferences from normal and High Definition (HD) to 4K STB consoles.

The introduction of OTT (Over The Top) streaming technologies and Internet Protocol Television (IPTV) are expected to ascertain the favorable growth prospects of the industry. The primary stakeholders involved in the market include direct broadcast satellite providers, telecom companies, and other on-demand content service providers.

Escalating demand for interactive content has culminated in prominent service providers forming strategic alliances with software and content providers to ensure seamless broadcast for users. There has been an increased emphasis on STBs with increased storage space for enabling personal video recording.

Increased availability of high-speed broadband internet services, particularly in metropolitan and semi-metro cities across the world is expected to impact the IPTV and OTT devices market favorably. Increased prominence of these innovative devices is expected to open significant growth avenues for 4K STBs over the forecast period.

Some of the prominent component and technology providers such as the U.S.-based system-on-chip (SoC) solutions provider Sigma Designs have introduced HRD support-enabled UHD STB SoCs thereby enabling them to offer a superior visual experience.

Have any Query? Ask our Experts:

https://www.grandviewresearch.com/inquiry/2848/ibb

Grand View Research has segmented the global 4K Set-top Box (STB) market on the basis of product:

4K Set-top Box (STB) Product Outlook (Volume, Thousand Units; Revenue, USD Billion, 2013 - 2024)

• IPTV
• Satellite
• DTT
• OTT
• Hybrid

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

The global dissolved gas analyzer market is estimated to reach a valuation of USD 1.11 billion by 2024 according to a new study by Grand View Research, Inc. The augmented demand to monitor the transformer health in order to increase operational efficiency is expected to significantly fuel the adoption of the product over the forecast period. Dissolved gas analyzers are primarily utilized to identify faults in the power transformers positioned at an early stage. This enables energy companies (utilities) to establish maintenance programs meant for repairing, avoiding faults, and extending the durability of power transformers.

The global electronics devices market (including consumer electronics and industrial electronics devices) is expected to be impacted significantly by COVID-19 as China is one of the major suppliers for the raw materials (used to manufacture devices) as well as the finished products. The industry is on the brink of facing a reduction in production, disruption in supply, and price fluctuations. While this can vastly encourage local manufacturers to step up and address the growing demand, the scarcity of raw material can still pose a challenge to this industry. The sales of prominent electronic companies is expected to be affected in the near future. The report will account for Covid19 as a key market contributor.

The growing awareness pertaining to the fault probability of high-voltage transformers, paired with the high cost of replacing depreciating transformers, has significantly escalated the product demand. Stringent safety and efficiency regulations imposed by the government of developed countries, such as the U.S., has instigated power transformer users to adopt dissolved gas analyzers. Additionally, the rising adoption of online Dissolved Gas Analysis (DGA), owing to benefits including the remote and continuous monitoring of transformer health, is expected to catapult the market growth over the forecast period.

The Digital Gas Analyzer (DGA) market is characterized by several technological trends. The surging demand for safe power transformers impels industrialists to innovate and find better technological solutions to fulfill the unmet needs of customers. For instance, in February 2013, Qualitrol introduced the new QNet4100 intelligent system for the alarm management and discrete event monitoring. With the widespread adoption of Industrial Internet of Thing (IIoT), a high level of automation may be witnessed in the entire fault detection process in the energy sector. Furthermore, the snowballing deployment of smart grid in the U.S., UK, Germany, China, and India would drive the adoption of gas analyzers to detect fault over the forecast period.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/dissolved-gas-analyzer-dga-market/request/rs1

Further key findings from the study suggest:

• On the basis of extraction type, the headspace extraction segment is anticipated to witness a robust growth at a far exceeding 14% over the forecast period. This can be attributed to the low risk of operator error from excessive handling of the sample during injection and preparation. In addition to this, the advantage of automating the process associated with this technique is also one of the key factors for the growth in the revenue of this particular segment. Vacuum extraction accounted for the majority market share in 2015 owing to the early development of this extraction technique
• The power rating segment comprises 100-500 MVA, 501-800 MVA, and 801-1200 MVA DGA devices. The 100-500 MVA power rating gas analyzers segment accounted for more than 60% of the overall revenue share in 2015 and is estimated to grow at a CAGR of more than 12% over the forecast period. The low price and low maintenance costs associated with these devices are one of the primary factors for the adoption of dissolved gas analyzers with these ratings
• On the basis of analysis type, the laboratory services segment accounted for over 35% of the overall revenue share in 2015. This is primarily attributed to the snowballing R&D investments for developing innovative and efficient methods for aging diagnostics. Furthermore, the growing emphasis by utilities on avoiding failures and lowering the maintenance cost is expected to drive the comprehensive DGA monitoring segment growth over the coming years
• The Asia-Pacific dissolved gas analyzers market is estimated to grow at a CAGR of more than 13% over the next eight years; this is due to the increased government spending in the industrial infrastructure projects as well as power transformers in order to expand the power capacity to meet the electricity shortage particularly across the emerging economies including India, China, and Indonesia. North America is expected to grow at a moderate pace mainly due to the escalating need to detect faults among the newly installed transformers paired with the growing demand for increasing the lifespan of the old transformers
• Notable players in the industry include ABB Ltd., Doble Engineering, General Electric, LumaSense Technologies, Morgan Schaffer Inc., Siemens, and Weidmann. The industry is technology driven and continuously evolving. Prominent industry players invest heavily in R&D activities for new product development and product enhancement in order to gaina competitive advantage.

The global dissolved gas analyzers (DGA) market is expected to reach USD 1.11 billion by 2024, expanding at a CAGR exceeding 12.0% over the forecast period. The growth is primarily attributed to the rising attentiveness concerning the likelihood of faults in the high-voltage transformers coupled with the high cost of substituting the depreciating transformers. Incorporating DGA aids companies in detecting faults in the installed power transformers at an initial stage. The early diagnosis empowers firms to organize maintenance programs to repair and avert faults and extend the endurance of power transformers. This is anticipated to fuel the product demand significantly over the next few years.

The snowballing adoption of online DGA is also one of the key factors contributing to the industry growth. In the current scenario, aging transformers are loaded heavily, which is one of the primary reasons to diagnose the health of transformers at the initial stage. Other factors, such as increased service reliability requirements and deferred capital expenditures on novel equipment in order to explore the usage of innovative transformer condition assessment and management tools, are expected to poise the growth of the market in the next eight years.

Online DGA plays a vital role in increasing the reliability of grids as it displays ratios of the key gasses and real-time values, which are essential parametersfor monitoring the transformer’s healthduring its operation. This results in reducing the transformer failure rate substantially, thereby decreasing the outages caused due to it. In addition, the efficiency and safety regulatory standards mandated by the government, including the U.S. government, for power transformers is expected to promote the DGA adoption over the forecast period.

Have any Query? Ask our Experts:

https://www.grandviewresearch.com/inquiry/3033/ibb

Grand View Research has segmented the dissolved gas analyzers market on the basis of extraction type, power rating, analysis type:

Dissolved Gas Analyzers Extraction Type Outlook (Revenue, USD Million, 2013 - 2024)

• Vacuum Extraction or Rack Method
• Head Space Extraction
• Stripper Column Method
• Others (Multiple Gas extractor)

Dissolved Gas Analyzers Power Rating Outlook (Revenue, USD Million, 2013 - 2024)

• 100 - 500 MVA
• 501 - 800 MVA
• 801 - 1200 MVA

Dissolved Gas Analyzers Analysis Type Outlook (Revenue, USD Million, 2013 - 2024)

• Smoke Alarms
• Early Warning DGA Monitoring
• Comprehensive DGA Monitoring
• Laboratory Services
• Database Software
• Portable DGA Devices

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.